Researchers developed a novel nanopigment for colorimetric pH sensing, ensuring linear accuracy from pH 1 to 10 with enhanced ...

H-E-B might be king in Texas, but that doesn't mean there can't be some healthy competition.

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be ImmunityBio (IBRX). The reason why I want to go over this biotech next is because it has had ...

Enrollment of BCG naïve subjects (QUILT-2.005) receiving BCG alone versus BCG plus ANKTIVA exceeding expectations 85% enrolled with anticipated completion in Q2 2026 with BLA filing to U.S. Food and ...

When Sean Frank became the CEO of accessory company Ridge in 2018, he set an ambitious goal for their primary product line of wallets: $100 million in total revenue. By the time he spoke on the ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced treatment with ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) demonstrates efficacy ...

At the turn of the 20th century, bovine tuberculosis, a bacterial disease that infected cows and spilled over to humans via milk ran rampant in France. Today, a weakened form of that same ...

Source: Getty Images BCG shortages and the fragile BCG supply chain created a bladder cancer treatment vacuum. Why? Manufacturing bottlenecks, the inherent complexity of producing a live-attenuated ...